Track topics on Twitter Track topics that are important to you
PARIS (dpa-AFX) - Sanofi (SNY, SNYNF) announced Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion for Sarclisa (isat...
Original Article: Sanofi: Sarclisa Gets Positive CHMP Opinion To Treat Multiple MyelomaNEXT ARTICLE
Sanofi-Aventis is a global pharmaceutical company with annual sales of $40,871m, placing it the second highest in the world. Although Sanofi-Aventis products are for a a very wide range of health problems, their major products are those for diabetes, o...